Related references
Note: Only part of the references are listed.The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke
Zachary B. Loris et al.
EXPERIMENTAL NEUROLOGY (2017)
P7C3 Attenuates the Scopolamine-Induced Memory Impairments in C57BL/6J Mice
Bo Jiang et al.
NEUROCHEMICAL RESEARCH (2016)
Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity
Zhao-xiang Ren et al.
ACTA PHARMACOLOGICA SINICA (2016)
Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke
Shu-Na Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2016)
GSK-3 beta mediates dexamethasone-induced pancreatic beta cell apoptosis
Bin Guo et al.
LIFE SCIENCES (2016)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis
A. K. Walker et al.
MOLECULAR PSYCHIATRY (2015)
P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage
Gelin Wang et al.
CELL (2014)
Neuroprotective Efficacy of a Proneurogenic Compound after Traumatic Brain Injury
Meghan O. Blaya et al.
JOURNAL OF NEUROTRAUMA (2014)
Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters
Jayne Loughery et al.
NUCLEIC ACIDS RESEARCH (2014)
The protease Omi regulates mitochondrial biogenesis through the GSK3β/PGC-1α pathway
R. Xu et al.
CELL DEATH & DISEASE (2014)
P7C3 Neuroprotective Chemicals Block Axonal Degeneration and Preserve Function after Traumatic Brain Injury
Terry C. Yin et al.
CELL REPORTS (2014)
Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse
Rita Perfeito et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)α/β by Protein Kinase C (PKC)α and Akt Promotes Thrombin-mediated Integrin αIIbβ3 Activation and Granule Secretion in Platelets
Samantha F. Moore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Astragaloside IV Inhibits Oxidative Stress-InducedMitochondrial Permeability Transition Pore Opening by Inactivating GSK-3 beta via Nitric Oxide in H9c2 Cardiac Cells
Yonggui He et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis
Rachel Tesla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease
Hector De Jesus-Cortes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell death
F. Chiara et al.
CELL DEATH & DISEASE (2012)
Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
A. Napolitano et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production
Alessandra Valerio et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Discovery of a Proneurogenic, Neuroprotective Chemical
Andrew A. Pieper et al.
CELL (2010)
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
Jonathan Wills et al.
EXPERIMENTAL NEUROLOGY (2010)
Mitochondrial calcium and the permeability transition in cell death
John J. Lemasters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
Agnes Petit-Paitel et al.
PLOS ONE (2009)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis
Andrea Rasola et al.
APOPTOSIS (2007)
Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: Relevance to oxidation damage in Parkinson's disease
Vellareddy Anantharam et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation
Pamela A. Lochhead et al.
MOLECULAR CELL (2006)
The MPTP model of Parkinson's disease
RJ Smeyne et al.
MOLECULAR BRAIN RESEARCH (2005)
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
JE Chipuk et al.
SCIENCE (2004)
Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53
P Watcharasit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of p53 by oxidative stress involves platelet-derived growth factor-β receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation
K Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
MPP plus analogs acting on mitochondria and inducing neuro-degeneration
Y Kotake et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage
P Watcharasit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Parkinson's disease:: one biochemical pathway to fit all genes?
R Krüger et al.
TRENDS IN MOLECULAR MEDICINE (2002)
Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3β
GN Bijur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation
S Frame et al.
MOLECULAR CELL (2001)
Share Paper
